Related references
Note: Only part of the references are listed.Cross-Link Structure Affects Replication-Independent DNA Interstrand Cross-Link Repair in Mammalian Cells
Erica M. Hlavin et al.
BIOCHEMISTRY (2010)
DNA interstrand crosslink repair in mammalian cells: step by step
Parameswary A. Muniandy et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
FANCM regulates DNA chain elongation and is stabilized by S-phase checkpoint signalling
Sarah Luke-Glaser et al.
EMBO JOURNAL (2010)
ATR activation and replication fork restart are defective in FANCM-deficient cells
Rebekka A. Schwab et al.
EMBO JOURNAL (2010)
Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes
Beate Neumann et al.
NATURE (2010)
Fanconi anemia and breast cancer susceptibility meet again
Ephrat Levy-Lahad
NATURE GENETICS (2010)
Mutation of the RAD51C gene in a Fanconi anemia-like disorder
Fiona Vaz et al.
NATURE GENETICS (2010)
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
Alfons Meindl et al.
NATURE GENETICS (2010)
How the Fanconi Anemia Pathway Guards the Genome
George-Lucian Moldovan et al.
ANNUAL REVIEW OF GENETICS (2009)
Structure, function and evolution of the XPD family of iron-sulfur-containing 5 '-> 3 ' DNA helicases
Malcolm F. White
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function
Natalie B. Collins et al.
BLOOD (2009)
Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma.
Danielle N. Yarde et al.
CANCER RESEARCH (2009)
Fanconi Anemia Complementation Group FANCD2 Protein Serine 331 Phosphorylation Is Important for Fanconi Anemia Pathway Function and BRCA2 Interaction
Gang Zhi et al.
CANCER RESEARCH (2009)
Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition
Maria J. Garcia et al.
CARCINOGENESIS (2009)
Effect of Cross-Link Structure on DNA Interstrand Cross-Link Repair Synthesis
Michael B. Smeaton et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Inactivation of Murine Usp1 Results in Genomic Instability and a Fanconi Anemia Phenotype
Jung Min Kim et al.
DEVELOPMENTAL CELL (2009)
MRE11-RAD50-NBS1 is a critical regulator of FANCD2 stability and function during DNA double-strand break repair
Celine Roques et al.
EMBO JOURNAL (2009)
Towards Antitumor Active trans-Platinum Compounds
Sheena M. Aris et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2009)
Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis
Younghoon Kee et al.
GENES & DEVELOPMENT (2009)
The Fanconi Anemia Protein FANCM Is Controlled by FANCD2 and the ATR/ATM Pathways
Alexandra Sobeck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Repair of Laser-localized DNA Interstrand Cross-links in G1 Phase Mammalian Cells
Parameswary A. Muniandy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
FANCI Binds Branched DNA and Is Monoubiquitinated by UBE2T-FANCL
Simonne Longerich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
XPF-ERCC1 Participates in the Fanconi Anemia Pathway of Cross-Link Repair
Nikhil Bhagwat et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors
Igor Landais et al.
MOLECULAR CANCER (2009)
Checkpoint Signaling from a Single DNA Interstrand Crosslink
Merav Ben-Yehoyada et al.
MOLECULAR CELL (2009)
Recruitment of Fanconi Anemia and Breast Cancer Proteins to DNA Damage Sites Is Differentially Governed by Replication
Xi Shen et al.
MOLECULAR CELL (2009)
Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: Mechanistic insights
Larry H. Thompson et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2009)
FANCM-FAAP24 and FANCJ: FA proteins that metabolize DNA
Abdullah Mahmood Ali et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2009)
The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities
Valeria Naim et al.
NATURE CELL BIOLOGY (2009)
The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair
Puck Knipscheer et al.
SCIENCE (2009)
Interstrand DNA cross-links induced by α,β-unsaturated aldehydes derived from lipid peroxidation and environmental sources
Michael P. Stone et al.
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Genetic Predisposition to Breast Cancer: Past, Present, and Future
Clare Turnbull et al.
Annual Review of Genomics and Human Genetics (2008)
Distortion-dependent unhooking of interstrand cross-links in mammalian cell extracts
Michael B. Smeaton et al.
BIOCHEMISTRY (2008)
Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24
Jung Min Kim et al.
BLOOD (2008)
Systemic cancer therapy: Evolution over the last 60 years
Grace K. Dy et al.
CANCER (2008)
Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer
Anna Potapova et al.
CANCER RESEARCH (2008)
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance
Elizabeth M. Swisher et al.
CANCER RESEARCH (2008)
Mechanism of replication-coupled DNA interstrand crosslink repair
Markus Raeschle et al.
CELL (2008)
Fanconi anemia proteins stabilize replication forks
Lily Chien Wang et al.
DNA REPAIR (2008)
The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly
Kanchan D. Mirchandani et al.
DNA REPAIR (2008)
Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin
Kyunghee Burkitt et al.
MOLECULAR CANCER (2008)
Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: Pathological significance in early- and late-onset breast carcinoma
Satyabrata Sinha et al.
MOLECULAR CANCER (2008)
FANCM and FAAP24 Function in ATR-Mediated Checkpoint Signaling Independently of the Fanconi Anemia Core Complex
Spencer J. Collis et al.
MOLECULAR CELL (2008)
Mechanistic Insight into Site-Restricted Monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI
Arno F. Alpi et al.
MOLECULAR CELL (2008)
ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer
Tetsuya Fujii et al.
LUNG CANCER (2008)
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Wataru Sakai et al.
NATURE (2008)
FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway
Masamichi Ishiai et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
Daniel T. Bergstralh et al.
TRENDS IN GENETICS (2008)
Deficiency in incisions produced by XPF at the site of a DNA interstrand cross-link in Fanconi anemia cells
Kandallu R. Kumaresan et al.
BIOCHEMISTRY (2007)
A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway
Martin A. Cohn et al.
MOLECULAR CELL (2007)
Deubiquitination of FANCD2 is required for DNA crosslink repair
Vibe H. Oestergaard et al.
MOLECULAR CELL (2007)
Contributions of DNA interstrand cross-links to aging of cells and organisms
Johannes Grillari et al.
NUCLEIC ACIDS RESEARCH (2007)
UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: A basis for the regulation of FANCD2 monoubiquitination
Arno Alpi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins
Weidong Wang
NATURE REVIEWS GENETICS (2007)
Psoralen and ultraviolet a light therapy for psoriasis
Robert S. Stern
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Proteasome function is required for DNA damage response and Fanconi anemia pathway activation
Celine Jacquemont et al.
CANCER RESEARCH (2007)
Fanconi anemia and DNA replication repair
Ketan J. Patel et al.
DNA REPAIR (2007)
DNA structure-induced recruitment and activation of the Fanconi anemia pathway protein FANCD2
A. Sobeck et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
FANCI is a second monoubiquitinated member of the Fanconi anemia pathway
Ashley E. Sims et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
Shuhei Matsuoka et al.
SCIENCE (2007)
Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated
Richard D. Kennedy et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents
Clark C. Chen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair
Agata Smogorzewska et al.
CELL (2007)
FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway
Chen Ling et al.
EMBO JOURNAL (2007)
A recurrent mutation in PALB2 in Finnish cancer families
Hannele Erkko et al.
NATURE (2007)
Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM
Alberto Ciccia et al.
MOLECULAR CELL (2007)
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2
Bing Xia et al.
NATURE GENETICS (2007)
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Sarah Reid et al.
NATURE GENETICS (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway
XiaoZhe Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
DNA interstrand cross-link repair in Saccharomyces cerevisiae
Peter Lehoczky et al.
FEMS MICROBIOLOGY REVIEWS (2007)
Disruption of the FA/BRCA pathway in bladder cancer
K. Neveling et al.
CYTOGENETIC AND GENOME RESEARCH (2007)
Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells
Jun Zhang et al.
CANCER BIOLOGY & THERAPY (2006)
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles
Sheila Seal et al.
NATURE GENETICS (2006)
Activation of Fanconi anemia pathway in cells with re-replicated DNA
Wenge Zhu et al.
CELL CYCLE (2006)
Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2
Barbara C. Godthelp et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2006)
Fanconi anaemia genes and susceptibility to cancer
C. G. Mathew
ONCOGENE (2006)
Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance
Gary P. H. Ho et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
FANCD2 associated with sporadic breast cancer risk
E. Barroso et al.
CARCINOGENESIS (2006)
UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation
Yuichi J. Machida et al.
MOLECULAR CELL (2006)
The role of BRCA2 in replication-coupled DNA interstrand cross-link repair in vitro
Lubos Cipak et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
An ATR- and BRCA1-mediated fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication
Wenge Zhu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options
Eike Gallmeier et al.
GASTROENTEROLOGY (2006)
Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway
D Chirnomas et al.
MOLECULAR CANCER THERAPEUTICS (2006)
DNA interstrand crosslink repair during G1 involves nucleotide excision repair and DNA polymerase ζ
S Sarkar et al.
EMBO JOURNAL (2006)
Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway
ZH Wang et al.
CANCER BIOLOGY & THERAPY (2006)
Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2
BC Godthelp et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2006)
Formation and repair of interstrand cross-links in DNA
DM Noll et al.
CHEMICAL REVIEWS (2006)
Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks
A Sobeck et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Molecular pathogenesis of Fanconi anemia: recent progress
Toshiyasu Taniguchi et al.
BLOOD (2006)
Fanconi anemia (cross)linked to DNA repair
LJ Niedernhofer et al.
CELL (2005)
The Fanconi Anemia/BRCA pathway: new faces in the crowd
RD Kennedy et al.
GENES & DEVELOPMENT (2005)
In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor
MS van der Heijden et al.
CLINICAL CANCER RESEARCH (2005)
The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells
YG Yang et al.
CARCINOGENESIS (2005)
A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M
AR Meetei et al.
NATURE GENETICS (2005)
The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells
Q Chen et al.
BLOOD (2005)
Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint
TS Byun et al.
GENES & DEVELOPMENT (2005)
The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway
SMB Nijman et al.
MOLECULAR CELL (2005)
Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM
S Hirano et al.
EMBO JOURNAL (2005)
Human fanconi anemia monoubiquitination pathway promotes homologous DNA repair
K Nakanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The Fanconi anemia core complex associates with chromatin during S phase
J Mi et al.
BLOOD (2005)
Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination
K Yamamoto et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The XPF-ERCC1 endonuclease and homologous recon bination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136
PH Clingen et al.
NUCLEIC ACIDS RESEARCH (2005)
The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways
P Pichierri et al.
EMBO JOURNAL (2004)
The genetics of FANCC and FANCG in familial pancreatic cancer
CD Rogers et al.
CANCER BIOLOGY & THERAPY (2004)
Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival
CJ Marsit et al.
ONCOGENE (2004)
The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair
W Niedzwiedz et al.
MOLECULAR CELL (2004)
ATR couples FANCD2 monoubiquitination to the DNA-damage response
PR Andreassen et al.
GENES & DEVELOPMENT (2004)
BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks
P Pichierri et al.
EMBO JOURNAL (2004)
Functional defects in the Fanconi anemia pathway in pancreatic cancer cells
MS Van der Heijden et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA
M Ferrer et al.
CANCER GENE THERAPY (2004)
Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin
XZ Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines
C Welsh et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Genetic steps of mammalian homologous repair with distinct mutagenic consequences
JM Stark et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
DNA damage-processing pathways involved in the eukaryotic cellular response to anticancer DNA cross-linking drugs
V Beljanski et al.
MOLECULAR PHARMACOLOGY (2004)
Phosphorylation of Fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway
FY Qiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin
Varinderpal S. Dhillon et al.
MOLECULAR CANCER (2004)
FANCG is phosphorylated at serines 383 and 387 during mitosis
J Mi et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Promoter hypermethylation of FANCF:: Disruption of Fanconi Anemia-BRCA pathway in cervical cancer
G Narayan et al.
CANCER RESEARCH (2004)
A novel ubiquitin ligase is deficient in Fanconi anemia
AR Meetei et al.
NATURE GENETICS (2003)
Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells
LJ Niedernhofer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells
K Yamamoto et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors
T Taniguchi et al.
NATURE MEDICINE (2003)
Nonerythroid all spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links
D Sridharan et al.
JOURNAL OF CELL SCIENCE (2003)
Naturally occurring coumarins inhibit human cytochromes P450 and block benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene DNA adduct formation in MCF-7 cells
HE Kleiner et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2003)
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
DI Kutler et al.
BLOOD (2003)
DNA interchain cross-links formed by acrolein and crotonaldehyde
ID Kozekov et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia
M Tischkowitz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Nucleotide excision repair- and polymerase eta-mediated error-prone removal of mitomycin C interstrand cross-links
HY Zheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51
T Taniguchi et al.
BLOOD (2002)
Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways
T Taniguchi et al.
CELL (2002)
Redox-modulated xenobiotic action and ROS formation: a mirror or a window?
G Pagano
HUMAN & EXPERIMENTAL TOXICOLOGY (2002)
Repair of DNA interstrand cross-links
MLG Dronkert et al.
MUTATION RESEARCH-DNA REPAIR (2001)
Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance
Peter J. McHugh et al.
LANCET ONCOLOGY (2001)
Recognition of cisplatin adducts by cellular proteins
M Kartalou et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function
SB Cantor et al.
CELL (2001)
Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity
SJ Gregson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair
X Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
BRCA2 is required for homology-directed repair of chromosomal breaks
ME Moynahan et al.
MOLECULAR CELL (2001)
Interaction of the fanconi anemia proteins and BRCA1 in a common pathway
I Garcia-Higuera et al.
MOLECULAR CELL (2001)
Repair of intermediate structures produced at DNA interstrand cross-links in Saccharomyces cerevisiae
PJ McHugh et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links
KR Kumaresan et al.
CARCINOGENESIS (2000)
Repair of endogenous DNA damage
T Lindahl et al.
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY (2000)